Your browser doesn't support javascript.
loading
Correction to: Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen.
Braal, C Louwrens; Hussaarts, Koen G A M; Seuren, Lieke; Oomen-deHoop, Esther; de Bruijn, Peter; Buck, Stefan A J; Bos, Monique E M M; Thijs-Visser, Martine F; Zuetenhorst, Hanneke J M; Mathijssen-van Stein, Daniëlle; Vastbinder, Mijntje B; van Leeuwen, Roelof W F; van Gelder, Teun; Koolen, Stijn L W; Jager, Agnes; Mathijssen, Ron H J.
Afiliação
  • Braal CL; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, CN, PO Box 2040, 3015, Rotterdam, The Netherlands. c.braal@erasmusmc.nl.
  • Hussaarts KGAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, CN, PO Box 2040, 3015, Rotterdam, The Netherlands.
  • Seuren L; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, CN, PO Box 2040, 3015, Rotterdam, The Netherlands.
  • Oomen-deHoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, CN, PO Box 2040, 3015, Rotterdam, The Netherlands.
  • de Bruijn P; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, CN, PO Box 2040, 3015, Rotterdam, The Netherlands.
  • Buck SAJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, CN, PO Box 2040, 3015, Rotterdam, The Netherlands.
  • Bos MEMM; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, CN, PO Box 2040, 3015, Rotterdam, The Netherlands.
  • Thijs-Visser MF; Department of Medical Oncology, Ikazia Hospital, Rotterdam, The Netherlands.
  • Zuetenhorst HJM; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Schiedam, The Netherlands.
  • Mathijssen-van Stein D; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Schiedam, The Netherlands.
  • Vastbinder MB; Department of Internal Medicine, IJsselland Hospital, Capelle Aan Den IJssel, The Netherlands.
  • van Leeuwen RWF; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, CN, PO Box 2040, 3015, Rotterdam, The Netherlands.
  • van Gelder T; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Koolen SLW; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, CN, PO Box 2040, 3015, Rotterdam, The Netherlands.
  • Mathijssen RHJ; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
Breast Cancer Res Treat ; 185(3): 889, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33226493

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda